Joseph H. Antin, MD, Dana-Farber Cancer Institute
Advertisement
Articles by Joseph H. Antin, MD, Dana-Farber Cancer Institute
Advertisement
Latest Updated Articles
Risk Factors for Graft-vs-Host DiseaseJune 19th 2020
Special Transplant SituationsJune 19th 2020
Members of the Transplant TeamJune 19th 2020
Timing of Referral for TransplantJune 19th 2020
Graft-vs-Host Disease Prophylaxis Clinical TrialsJune 19th 2020
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
2
ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer
3
Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer
4
European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma
5